abdominopelvic lymphnode oligometastasis
Conditions
Interventions
Before every fraction of the radiotherapy, a CT scan will be made.
abdomen
oligometastasis
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: * Indication to SBRT after discussion in Institutional Tumor Board * Patients with abdominal and/or pelvic lymph node metastases of solid tumors * No more than 5 metastatic lesions in no more than 2 organs and a controlled primary tumor site * Diagnostic imaging includes at least a PET-scan and CT *thorax/abdomen, of which one is not older than 4 weeks at the time of referral for SBRT. * Primary tumor must be treated at least 4 months before the diagnosis of the metastasis * Patients must be 18 years or older
Exclusion criteria
Exclusion criteria: * Prior radiotherapy in the same field. * Second primary malignancy except in situ carcinoma of the cervix, adequately treated non-melanoma skin cancer, or other malignancy treated at least 3 years previously without evidence of recurrence. * Pregnancy. * Serious concomitant systemic disorders that would compromise the safety of the patient or his/her ability to complete the study, at the discretion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determine local control of Stereotactic radiotherapy treatment in patients with abdominal and pelvic lymph node oligometastases. | — |
Secondary
| Measure | Time frame |
|---|---|
| Determine overall survival Toxicity of treatment ( NCI CTCAE). | — |
Countries
The Netherlands
Outcome results
None listed